Hyperhomocysteinemia and B-vitamin status after discontinuation of oral anticoagulation therapy in patients with a history of venous thromboembolism

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 11, 2003, Pages 1493-1497

  Sobczyńska Malefora, Agata ^a   Harrington, Dominic J ^a   Rangarajan, Savita ^a   Kovacs, Jo Anne ^a   Shearer, Martin J ^a   Savidge, Geoffrey F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation therapy; Homocysteine; Hyperhomocysteinemia; Red cell folate; Venous thromboembolism; Vitamin B12

Indexed keywords

ANTICOAGULANT AGENT; FOLIC ACID; HEPARIN; HOMOCYSTEINE; VITAMIN B GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; ERYTHROCYTE LEVEL; FEMALE; FOOD INTAKE; HUMAN; HYPERHOMOCYSTEINEMIA; LEAFY VEGETABLE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; STATISTICAL ANALYSIS; UNITED KINGDOM; VEIN THROMBOSIS; VITAMIN BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME; THROMBOEMBOLISM; VITAMIN B 12; WARFARIN;

EID: 0344306683     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.229     Document Type: Article

References (21)

1. Homocysteine Studies Collaboration. Homocysteine and Risk of Ischemic Heart Disease and Stroke. A Meta-analysis. J Am Med Assoc 2002; 288:2015-23.
2. Heijer M, Rosendaal FR, Blom HJ, Gerrits WBJ, Bos GMJ. Hyperhomocysteinemia and venous thrombosis: a metaanalysis. Thromb Haemost 1998; 80:874-7.
3. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from meta-analysis. Br Med J 2002; 325:1202-6.
4. Hirsh J. The optimal duration of anticoagulant therapy for venous thrombosis. N Engl J Med 1995; 332:1710-1.
5. Bostom AG, Jacques PF, Liaugaudas G, Rogers G, Rosenberg IH, Selhub J. Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Biol 2002; 22:488-91.
6. Clarke R. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J 1998; 316:894-8.
7. Fiskerstrand, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39:263-71.
8. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39:1764-79.
9. Arruda VR, von Zoben PM, Chiamparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77:818-21.
10. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, deRonde H, et al. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994; 369:64-7.
11. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-703.
12. 12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. Thromb Haemost 2000; 83:563-70.
13. Morelli VM, Lourenço DM, D'Almeida V, Franco RF, Miranda F, Zago MA, et al. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis 2002; 13:271-5.
14. Ubbink JB, Becker PJ, Vermaak WJH, Delport R. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995; 41:1033-7.
15. Quéré I, Perneger TV, Zittoun J, Gris JC, Daures JP, Schved JF, et al. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet 2002; 359:747-52.
16. 1) content of foods. Br J Nutr 2000; 83:389-99.
17. Brouwer IA, Dusseldorp M, West CE, Meyboom S, Thomas CMG, Duran M, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr 1999; 129:1135-9.
18. Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, et al. Dietary counseling to increase natural folate intake: a randomized, placebo-controlled trial in free-living subjects to assess effects on serum folate and plasma total homocysteine. Am J Clin Nutr 2002; 76:758-65.
19. Silaste MJ, Rantala M, Alfthan G, Aro A, Kesaniemi YA. Plasma homocysteine concentration is decreased by dietary intervention. Br J Nutr 2003; 89:295-301.
20. Murúa A, Quintana I, Galarza C, Alfie J, Kordich L. Unsuspected hyperhomocysteinemia in chronically anticoagulated patients. Blood Coagul Fibrinolysis 2001; 12:79-80.
21. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr 1998; 128:785-8.